Literature DB >> 31101444

Non-Invasive Vascular Very-High Resolution Ultrasound to Quantify Artery Intima Layer Thickness: Validation of the Four-Line Pattern.

Johnny K M Sundholm1, Anders Paetau2, Anders Albäck3, Tom Pettersson4, Taisto Sarkola5.   

Abstract

Preliminary findings suggest that very-high resolution ultrasound (VHRU, 55 MHz) could differentiate arterial intima layer thickness (IT) non-invasively in vivo. We aimed to validate ultrasound-derived IT measurements and describe a four-line pattern consistent with intimal thickening. VHRU was applied to temporal arteries of 37 patients with suspected giant cell arteritis without inflammation on histology. Anatomically matched ultrasound-derived measurements of arterial layer thickness with the leading-edge method was compared to histology. Intimal thickening (IT >0.06 mm on histology) was identified as a four-line pattern in VHRU with a sensitivity of 96.3% and a specificity of 100%. Histologic and VHRU IT measurement agreement was excellent (mean difference 0.007 mm; 95% limits of agreement, -0.043 to 0.057) and intra-class coefficient (ICC) 0.923 (95% confidence interval [CI], 0.833-0.964). Intra- and inter-observer agreements for VHRU IT were high: ICC 0.946 (95% CI, 0.877-0.976) and 0.872 (95% CI, 0.773-0.943). VHRU utilizing the leading-to-leading edge method allows accurate and reliable measurements of arterial IT in patients with IT >0.06 mm. Measurements of IT will provide the opportunity to explore early subclinical structural intimal changes in the arterial wall increasing with age.
Copyright © 2019 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Intima thickness; Intima-media thickness; Methodology; Ultrasound biomicroscopy; Vascular imaging; Very-high resolution ultrasound

Mesh:

Year:  2019        PMID: 31101444     DOI: 10.1016/j.ultrasmedbio.2019.04.017

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  7 in total

1.  Intraoperative Epicardial Ultra-High Frequency Ultrasound in Coronary Artery Bypass Grafting Surgery.

Authors:  Ashley V Fritz; Archer K Martin; Erol Belli; Steven R Clendenen
Journal:  Cureus       Date:  2022-02-27

2.  Ultra-high frequency ultrasound delineated changes in carotid and muscular artery intima-media and adventitia thickness in obese early middle-aged women.

Authors:  Johnny Km Sundholm; Linda Litwin; Kristiina Rönö; Saila B Koivusalo; Johan G Eriksson; Taisto Sarkola
Journal:  Diab Vasc Dis Res       Date:  2022 May-Jun       Impact factor: 3.541

3.  Risk factors during first 1,000 days of life for carotid intima-media thickness in infants, children, and adolescents: A systematic review with meta-analyses.

Authors:  Adina Mihaela Epure; Magali Rios-Leyvraz; Daniela Anker; Stefano Di Bernardo; Bruno R da Costa; Arnaud Chiolero; Nicole Sekarski
Journal:  PLoS Med       Date:  2020-11-23       Impact factor: 11.069

4.  Protocol: A randomized controlled trial to assess effectiveness of a 12-month lifestyle intervention to reduce cardiovascular disease risk in families ten years after pre-eclampsia (FINNCARE).

Authors:  Tiina Jääskeläinen; Anni Kivelä; Michelle Renlund; Seppo Heinonen; Minna Aittasalo; Hannele Laivuori; Taisto Sarkola
Journal:  Prev Med Rep       Date:  2022-02-08

Review 5.  Evolution of ultrasound in giant cell arteritis.

Authors:  Colm Kirby; Rachael Flood; Ronan Mullan; Grainne Murphy; David Kane
Journal:  Front Med (Lausanne)       Date:  2022-10-03

6.  Diagnostic performance and utility of very high-resolution ultrasonography in diagnosing giant cell arteritis of the temporal artery.

Authors:  Johnny K M Sundholm; Tom Pettersson; Anders Paetau; Anders Albäck; Taisto Sarkola
Journal:  Rheumatol Adv Pract       Date:  2019-07-05

Review 7.  Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides.

Authors:  Valentin Sebastian Schäfer; Lei Jin; Wolfgang Andreas Schmidt
Journal:  Curr Rheumatol Rep       Date:  2020-09-21       Impact factor: 4.592

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.